Product NDC: | 0074-4317 |
Proprietary Name: | Zemplar |
Non Proprietary Name: | Paricalcitol |
Active Ingredient(s): | 1 ug/1 & nbsp; Paricalcitol |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, LIQUID FILLED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0074-4317 |
Labeler Name: | AbbVie Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021606 |
Marketing Category: | NDA |
Start Marketing Date: | 20100614 |
Package NDC: | 0074-4317-30 |
Package Description: | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (0074-4317-30) |
NDC Code | 0074-4317-30 |
Proprietary Name | Zemplar |
Package Description | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (0074-4317-30) |
Product NDC | 0074-4317 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Paricalcitol |
Dosage Form Name | CAPSULE, LIQUID FILLED |
Route Name | ORAL |
Start Marketing Date | 20100614 |
Marketing Category Name | NDA |
Labeler Name | AbbVie Inc. |
Substance Name | PARICALCITOL |
Strength Number | 1 |
Strength Unit | ug/1 |
Pharmaceutical Classes | Cholecalciferol [Chemical/Ingredient],Vitamin D3 Analog [EPC] |